CA2281789A1 - Compositions antiinflammatoires pour application nasale topique - Google Patents

Compositions antiinflammatoires pour application nasale topique Download PDF

Info

Publication number
CA2281789A1
CA2281789A1 CA002281789A CA2281789A CA2281789A1 CA 2281789 A1 CA2281789 A1 CA 2281789A1 CA 002281789 A CA002281789 A CA 002281789A CA 2281789 A CA2281789 A CA 2281789A CA 2281789 A1 CA2281789 A1 CA 2281789A1
Authority
CA
Canada
Prior art keywords
composition
agent
group
nasal
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002281789A
Other languages
English (en)
Inventor
Catherine A. Segal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2281789A1 publication Critical patent/CA2281789A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des compositions pour application nasale topique, qui renferment une quantité thérapeutiquement efficace d'agent antiinflammatoire et une quantité thérapeutiquement efficace d'au moins un agent choisi parmi le groupe suivant : vasoconstricteur, inhibiteur de neuramidinase, inhibiteur de leucotriène, antihistaminique, antiallergique, anticholinergique, anesthésique et mucolytique. Ces compositions sont utiles sous forme de pulvérisations ou de gouttes nasales, pour le traitement d'affections du nez et des sinus.
CA002281789A 1997-04-30 1998-04-02 Compositions antiinflammatoires pour application nasale topique Abandoned CA2281789A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4430697P 1997-04-30 1997-04-30
US60/044,306 1997-04-30
PCT/US1998/006483 WO1998048839A1 (fr) 1997-04-30 1998-04-02 Compositions antiinflammatoires pour application nasale topique

Publications (1)

Publication Number Publication Date
CA2281789A1 true CA2281789A1 (fr) 1998-11-05

Family

ID=21931638

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002281789A Abandoned CA2281789A1 (fr) 1997-04-30 1998-04-02 Compositions antiinflammatoires pour application nasale topique

Country Status (8)

Country Link
EP (1) EP0979105A1 (fr)
JP (1) JP2001524108A (fr)
CN (1) CN1253508A (fr)
AU (1) AU6878098A (fr)
BR (1) BR9809022A (fr)
CA (1) CA2281789A1 (fr)
IL (1) IL131492A0 (fr)
WO (1) WO1998048839A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1159012C (zh) * 1997-08-26 2004-07-28 阿旺蒂斯制药公司 用于组合哌啶子基烷醇-减充血剂的药物组合物
HUP0101369A3 (en) * 1997-12-23 2002-11-28 Schering Corp Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
US6384038B1 (en) * 1998-04-14 2002-05-07 Sepracor Inc. Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
GB9822170D0 (en) * 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
US6576224B1 (en) * 1999-07-06 2003-06-10 Sinuspharma, Inc. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
IT1313567B1 (it) * 1999-07-27 2002-09-09 Zambon Spa Uso della n-acetil-cisteina per la preparazione di composizionifarmaceutiche topiche per il trattamento di patologie allergiche delle
DE10007203A1 (de) 2000-02-17 2001-08-23 Asta Medica Ag Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
PL208686B1 (pl) 2001-09-18 2011-05-31 Nycomed Danmark Aps Kompozycja w postaci roztworu wodnego do leczenia przeziębienia oraz zastosowanie połączenia ipratropium lub jego soli i ksylometazoliny lub jej soli
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
NZ537186A (en) * 2002-06-20 2006-10-27 Novartis Consumer Health S Nasal compositions comprising a mucopolysaccharide and propylene glycol
PT1545548E (pt) 2002-08-30 2010-09-02 Nycomed Gmbh Utilização da combinação de ciclesonida e anti-histamínicos para o tratamento de rinite alérgica
WO2005013963A1 (fr) * 2003-08-06 2005-02-17 Galephar M/F Combinaisons avantageuses pour inhalation de nacystelyn et de bronchodilatateurs
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
ES2704482T3 (es) 2004-11-24 2019-03-18 Meda Pharmaceuticals Inc Composiciones que comprenden azelastina y sus métodos de uso
JP4991693B2 (ja) * 2005-03-16 2012-08-01 メダ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 呼吸器疾患の治療のための抗コリン作用薬及びロイコトリエン受容体アンタゴニストの組み合わせ剤
DE602006021452D1 (de) * 2005-08-26 2011-06-01 Meiji Dairies Corp Antiallergisches mittel
EP2851064A3 (fr) * 2006-07-11 2015-08-05 Roy C. Levitt Prévention de la rhinosinusite et thérapie avec des inhibiteurs de cytokine proinflammatoires
JP2008143845A (ja) * 2006-12-11 2008-06-26 Hoshienu Seiyaku Kk 点鼻薬組成物及び点鼻薬液噴霧器具
JP2015518006A (ja) * 2012-05-25 2015-06-25 エクスクリア インコーポレイテッド キシリトール系の抗粘膜組成物及び関連する方法並びに組成物
CN104667256B (zh) * 2015-03-18 2017-05-03 江苏威克斯医疗科技有限公司 一种鼻腔粘膜纤毛护理冲洗液及其用途
CN107753485A (zh) * 2017-11-28 2018-03-06 赵永宏 一种兼有鼻减充血和麻醉作用的药物组合物及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3482015A (en) * 1965-02-08 1969-12-02 Merck & Co Inc Aerosol composition of phenylephrine tartrate and the production of such
US4053628A (en) * 1971-05-12 1977-10-11 Fisons Limited Composition
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
JPH0753671B2 (ja) * 1985-12-26 1995-06-07 積水化学工業株式会社 経皮・経粘膜製剤
ES2137981T3 (es) * 1991-11-19 2000-01-01 Univ Virginia Tratamiento combinado por agentes antimediaticos y antiviricos de resfriados comunes.
AU7604094A (en) * 1993-09-07 1995-03-27 Procter & Gamble Company, The Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
WO1997001341A1 (fr) * 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. Combinaison d'agents de stabilisation de mastocytes nasaux topiques avec des steroides nasaux topiques
WO1997001337A1 (fr) * 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. Combinaison d'antihistamines et de steroides a application topique par voie nasale
DE19532714A1 (de) * 1995-09-05 1997-03-06 Bayer Ag Kombination von 5-Lipoxygenase- und Leukotriensynthese Inhibitoren mit Glucocorticosteroiden
EP0780127A1 (fr) * 1995-12-19 1997-06-25 The Procter & Gamble Company Pulvérisateur nasale contenant un stéréoide et un antihistamine

Also Published As

Publication number Publication date
WO1998048839A1 (fr) 1998-11-05
JP2001524108A (ja) 2001-11-27
EP0979105A1 (fr) 2000-02-16
BR9809022A (pt) 2000-08-01
AU6878098A (en) 1998-11-24
IL131492A0 (en) 2001-01-28
CN1253508A (zh) 2000-05-17

Similar Documents

Publication Publication Date Title
CA2281789A1 (fr) Compositions antiinflammatoires pour application nasale topique
EP1227812B1 (fr) Traitement nasal topique avec la desloratadine et furoate du mometasone
AU651089B2 (en) Treatment of sinus headache
JP4500045B2 (ja) 感冒の治療のための組成物
US20050281751A1 (en) Directed intranasal administration of pharmaceutical agents
JPH11511758A (ja) 鼻腔用ステロイドと抗ヒスタミン剤を含む鼻腔内噴霧薬
EP0780127A1 (fr) Pulvérisateur nasale contenant un stéréoide et un antihistamine
US20030049322A1 (en) Aqueous-based pharmaceutical composition
US9301936B2 (en) Pharmaceutical formulations of tranexamic acid and their use
AU2012216890A1 (en) Combination of glycopyrrolate and a beta2 -agonist
US20020193417A1 (en) Nasal solutions
WO2010054093A1 (fr) Formulations destinées au traitement des douleurs de l’herpès-zona aigu
RU2472499C2 (ru) Лекарственное средство, включающее комбинацию активных веществ, содержащую пантотеновую кислоту или ее производные, для лечения аллергических симптомов
JPH0269413A (ja) アレルギー性鼻炎の治療方法
JP4521117B2 (ja) 偏頭痛、群発性頭痛、緊張性頭痛、血管疾患に伴う頭痛、耳鳴りまたは筋肉性頭痛を治療するための医薬
RU2005135332A (ru) Назальные фармацевтические композиции и способы их применения
ES2340777T3 (es) Metodo de tratamiento de la rinosinusitis aguda.
JPS6034909A (ja) いびき止め剤
US4385048A (en) Methods for the treatment of nasal hypersecretion
US20110201582A1 (en) Method and composition for treatment of skin conditions
McAllen et al. Intranasal flunisolide, placebo and beclomethasone dipropionate in perennial rhinitis
US7332528B2 (en) DRI nasal sprays
MXPA99007597A (en) Topical nasal antiinflammatory compositions
EA009990B1 (ru) Синергетическая комбинация, включающая рофлумиласт и r,r-формотерол
Martini et al. Nasal and pulmonary drug delivery systems

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 20020402